Kriya Therapeutics
Kriya Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded in 2019 that designs, develops and manufactures one-time AAV gene therapies for chronic diseases that affect large patient populations, rather than for ultra-rare indications alone. It is headquartered at 1219 Shiloh Glenn Drive in Durham, North Carolina, inside Research Triangle Park, with additional operations in Palo Alto, California, and has raised more than $900 million across Series A ($80M, 2020), Series B ($100M, 2021), Series C (over $430M including a $150M extension, 2022-2023) and Series D ($320M, September 2025). Its pipeline spans three therapeutic areas: ophthalmology (geographic atrophy, thyroid eye disease including KRIYA-586), metabolic disease (Type 1 diabetes, MASH/NASH, an investigational AAV-FGF21 program) and neurology (trigeminal neuralgia, added through the 2022 acquisition of Redpin Therapeutics). The company operates a vertically integrated engine that pairs computational product design with in-house GMP manufacturing — the same unit operations from 1L research scale through 50L, 500L and 3,000L bioreactor scale, with Akta chromatography purification, vial filling and in-house analytical characterization of critical quality attributes. It was selected for the FDA PreCheck Pilot Program in June 2026. Kriya Therapeutics runs no developer program and publishes no product API, no developer portal and no API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind kriyatherapeutics.com, catalogued here.
Kriya Therapeutics publishes 1 API contract indexed on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Gene Therapy, and AAV.
Kriya Therapeutics’ developer surface includes product news, support, authentication, and 27 more developer resources.
Kin Score
Kin Score
How this is scored →scored 2026-11-06 · rubric v0.27.0
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/kriya-therapeutics/"><img src="https://apis.io/badge/kriya-therapeutics/card.svg" alt="Kriya Therapeutics on APIs.io — Kin Score by API Evangelist"></a>Other styles, a README pill and a shields.io endpoint are on the badge page.
- Machine-Readable Contract +18 pts — api_specs includes an OpenAPI document
- MCP Server +12 pts — deployment.mode + probe verdict on the mcp/ manifest, not the pointer; an unprobed slug falls back to authorship
- Agentic Access Contract +10 pts — agentic_access artifact present (x-agentic-access), graded by author
- Idempotency +9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
- A2A Agent Card +8 pts — a2a/
-a2a.yml manifest, graded on conformance.grade against A2A 1.0.0 - Rate-Limit Signaling +7 pts — OpenAPI responses document X-RateLimit-* / RateLimit headers (verified), else a rate_limits artifact or RateLimits link (documented)
- Contract Quality scores 0.0 — up to +25.0 composite points
- Access Clarity scores 21.1 — up to +15.8 composite points
- Developer Ergonomics scores 23.2 — up to +15.4 composite points
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Cell & Gene Therapy | standard | 34.5 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Kriya Therapeutics Website (WordPress REST)
The public WordPress REST API (wp-json) of the Kriya Therapeutics website at kriyatherapeutics.com: the route index of the site's content management system, catalogued as one si...
Agent Skills 3
Packaged agent skills for driving this provider's APIs from an AI assistant.
OpenAPI Overlays 1
Overlays applied on top of this provider's contracts. Each card says who wrote it: a document the provider publishes, or one API Evangelist derived or generated.
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 4
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 8
Properties that don't map to a standard resource type
Scroll for all 8
Source (apis.yml)
Kriya Therapeutics API — frequently asked questions
Does Kriya Therapeutics have an API?
Yes. APIs.io lists 1 API from Kriya Therapeutics, including Kriya Therapeutics Website (WordPress REST).
How do I authenticate with the Kriya Therapeutics API?
Kriya Therapeutics uses bearer-token authentication (none/apiKey/http · 3 schemes). The details are profiled on APIs.io as Kriya Therapeutics Authentication.
Is the Kriya Therapeutics API ready for AI agents?
Kriya Therapeutics has a Kin Score of 16.3 out of 100 (emerging) and an Agent Readiness score of 6.3 (agent-aware), scored by API Evangelist on 2026-11-06.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.